Recent studies have shown an increased risk of myocardial infarction (heart attacks) and ischemic stroke associated with the use of testosterone therapy products. Such products, including AndroGel, Axiron, and Androderm, are thought to be increasing the risk of such serious cardiovascular issues.
The risk of heart attack and stroke for a user of testosterone products nearly doubles when compared to those who don’t use testosterone. Given the enormous (and growing) sales of prescription testosterone products, this could mean a large number of heart attacks have occurred in the general population that otherwise would not have occurred. See links to helpful information below. We are now accepting these cases. Call for free consulation andask for Jamie Sheller1 800 883 2299.
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0085805
http://www.nejm.org/doi/full/10.1056/NEJMoa1000485
http://www.research.va.gov/currents/winter2013-14/winter2013-14-9.cfm
http://jama.jamanetwork.com/article.aspx?articleid=1764030

The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.